Bio Pharma Dive
OCTOBER 6, 2023
The funding, which is part of ACT for ALS, will support expanded access studies of drugs developed by Prilenia Therapeutics, Clene Nanomedicine and Rapa Therapeutics.
Pharmaceutical Technology
OCTOBER 6, 2023
Ocular Therapeutix has confirmed the launch of a trial of an intravitreal eye implant intended to combat macular degeneration.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
OCTOBER 6, 2023
The negative panel vote likely means Amgen will need more data to support a full approval for its conditionally cleared lung cancer drug Lumakras.
Pharma Times
OCTOBER 6, 2023
The study used data from 50,000 people in the UK Biobank - News - PharmaTimes
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Bio Pharma Dive
OCTOBER 6, 2023
Regulators’ holdup of the deal had stoked investor fears of greater scrutiny on M&A. In the end, Amgen agreed to requirements meant to guard against product “bundling.
Pharmaceutical Technology
OCTOBER 6, 2023
Biologics are poised to overtake innovative small molecules in terms of sales revenue by 2027, with forecast sales of $120bn.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Fierce Pharma
OCTOBER 6, 2023
While the White House recently touted the FDA’s efforts to mitigate the ongoin | The National Comprehensive Cancer Network found that 72% of centers are still experiencing a carboplatin shortage, while 59% remain low on cisplatin. The survey follows a June report which found that nearly all centers had short supply of the chemotherapies.
Pharmaceutical Technology
OCTOBER 6, 2023
Tuttle and colleagues recognized that patients with T2D and CKD are limited in their therapeutic use because their low eGFR.
Fierce Pharma
OCTOBER 6, 2023
Amgen has completed its $27.8 billion acquisition of Horizon Therapeutics after fending off a legal challenge by the U.S. antitrust watchdog. | Amgen has completed its $27.8 billion acquisition of Horizon Therapeutics after fending off a legal challenge by the U.S. antitrust watchdog.
Pharmaceutical Technology
OCTOBER 6, 2023
TREAT California started collecting signatures for a 5 November ballot measure that aims to raise money for psychedelic therapy research.
Fierce Pharma
OCTOBER 6, 2023
People who use Novo Nordisk’s popular weight-loss drugs are taking on a small risk of developing severe stomach problems, according to research conducted by the University of British Columbia and < | People who use Novo Nordisk’s popular weight-loss drugs are taking on a small risk of developing severe stomach problems, according to research conducted by the University of British Columbia.
Pharmaceutical Technology
OCTOBER 6, 2023
Serum is already India's most valuable unlisted company, and it is looking to expand its offering into wealthier nations.
pharmaphorum
OCTOBER 6, 2023
UK launches total-body PET drive to support drug discovery Phil.
Pharmaceutical Technology
OCTOBER 6, 2023
The expansion at the St. Louis (Missouri) would include up to four bioreactors to accommodate the production of biologic therapies.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Fierce Pharma
OCTOBER 6, 2023
Aiming to hit a corporate value of around $15 billion by the end of the decade, Korean CDMO Lotte Biologics has laid out plans to stand up three new manufacturing facilities in the same time frame. | Lotte this week unveiled a land purchase agreement with the Incheon Free Economic Zone Authority in Incheon, Korea. With the new real estate, Lotte plans to build out three separate bio plants by 2030.
Pharmaceutical Technology
OCTOBER 6, 2023
The panel identified several issues with the trial including study organisation and loss of follow-up data from patients who withdrew consent.
pharmaphorum
OCTOBER 6, 2023
What AI really means for biology and the pharmaceutical industry Mike.
Pharmaceutical Technology
OCTOBER 6, 2023
Emergex and Saudi Vaccine Industrial Company (VIC) will develop T cell-priming immune set-point candidates against infectious diseases.
Pharmaceutical Technology
OCTOBER 6, 2023
Agomab Therapeutics FSCD therapy has received the US Food and Drug Administration (FDA)'s fast track designation
pharmaphorum
OCTOBER 6, 2023
Empowering health through innovation: Smartwatches as diagnostic aids Mike.
Pharmaceutical Technology
OCTOBER 6, 2023
GSK has announced plans to divest its 2.9% stake in consumer healthcare company Haleon for £885.6m ($1.07bn).
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
pharmaphorum
OCTOBER 6, 2023
Orchard will help Kyowa Kirin grow in gene therapy Phil.
Pharmaceutical Technology
OCTOBER 6, 2023
AbbVie has acquired discovery-stage biotechnology company Mitokinin in a deal totalling $655m, to bolster its neuroscience pipeline.
pharmaphorum
OCTOBER 6, 2023
FDA panel sceptical on Lumakras confirmatory data Phil.
Pharmaceutical Technology
OCTOBER 6, 2023
Genomics company Twist Bioscience has entered into an antibody discovery, option and licence agreement with German drug manufacturer Bayer.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmaceutical Commerce
OCTOBER 6, 2023
Conference hosts roundtable chats, with topics ranging from data-driven decision making to cold chain logistics.
pharmaphorum
OCTOBER 6, 2023
Boehringer moves obesity therapy into phase 3 Phil.
Pharmaceutical Commerce
OCTOBER 6, 2023
Sr. Director of Community Engagement for Pharmaceuticals at GS1 US explains what the implementation guidelines are meant to accomplish.
Intouch Solutions
OCTOBER 6, 2023
Working at EVERSANA INTOUCH means being surrounded by forward-thinking, highly innovative and creative individuals who strive to think differently. Recently, a group of EVERSANA INTOUCHers began a new internal series called “Brainspo.” The idea for Brainspo began as an internal pilot within the EVERSANA INTOUCH Oxygen affiliate and came out of wanting to get people out of their day-to-day and spend 15 minutes of thought-provoking conversation together, once a week, to open minds and ultimately g
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Expert insights. Personalized for you.
321 
Let's personalize your content